CGN Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.94M | Buy |
26,544
+373
| +1% | +$41.4K | 0.26% | 83 |
|
|
2025
Q1 | $2.93M | Sell |
26,171
-4,785
| -15% | -$536K | 0.29% | 80 |
|
|
2024
Q4 | $2.86M | Sell |
30,956
-759
| -2% | -$70.1K | 0.28% | 82 |
|
|
2024
Q3 | $2.66M | Buy |
31,715
+4,656
| +17% | +$390K | 0.27% | 93 |
|
|
2024
Q2 | $1.86M | Buy |
27,059
+24,186
| +842% | +$1.66M | 0.22% | 117 |
|
|
2024
Q1 | $210K | Sell |
2,873
-3,142
| -52% | -$230K | 0.03% | 246 |
|
|
2023
Q4 | $487K | Sell |
6,015
-26,462
| -81% | -$2.14M | 0.07% | 180 |
|
|
2023
Q3 | $2.43M | Buy |
32,477
+892
| +3% | +$66.8K | 0.33% | 84 |
|
|
2023
Q2 | $2.43M | Buy |
31,585
+4,187
| +15% | +$323K | 0.35% | 78 |
|
|
2023
Q1 | $2.27M | Buy |
27,398
+2,014
| +8% | +$167K | 0.36% | 76 |
|
|
2022
Q4 | $2.18M | Buy |
25,384
+7,650
| +43% | +$657K | 0.38% | 70 |
|
|
2022
Q3 | $1.09M | Buy |
17,734
+3,823
| +27% | +$236K | 0.27% | 100 |
|
|
2022
Q2 | $860K | Buy |
13,911
+4,450
| +47% | +$275K | 0.24% | 103 |
|
|
2022
Q1 | $562K | Buy |
9,461
+2,049
| +28% | +$122K | 0.14% | 140 |
|
|
2021
Q4 | $538K | Buy |
7,412
+278
| +4% | +$20.2K | 0.14% | 140 |
|
|
2021
Q3 | $498K | Buy |
7,134
+568
| +9% | +$39.7K | 0.16% | 132 |
|
|
2021
Q2 | $452K | Buy |
6,566
+198
| +3% | +$13.6K | 0.14% | 140 |
|
|
2021
Q1 | $412K | Buy |
6,368
+522
| +9% | +$33.8K | 0.15% | 133 |
|
|
2020
Q4 | $341K | Buy |
+5,846
| New | +$341K | 0.14% | 141 |
|